@article {7443,
	title = {International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma},
	journal = {The Lancet Oncology},
	volume = {17},
	year = {2016},
	note = {Cited By :9Export Date: 21 February 2017},
	month = {2016},
	pages = {e328 - e346},
	abstract = {Treatment of multiple myeloma has substantially changed over the past decade with the introduction of several classes of new effective drugs that have greatly improved the rates and depth of response. Response criteria in multiple myeloma were developed to use serum and urine assessment of monoclonal proteins and bone marrow assessment (which is relatively insensitive). Given the high rates of complete response seen in patients with multiple myeloma with new treatment approaches, new response categories need to be defined that can identify responses that are deeper than those conventionally defined as complete response. Recent attempts have focused on the identification of residual tumour cells in the bone marrow using flow cytometry or gene sequencing. Furthermore, sensitive imaging techniques can be used to detect the presence of residual disease outside of the bone marrow. Combining these new methods, the International Myeloma Working Group has defined new response categories of minimal residual disease negativity, with or without imaging-based absence of extramedullary disease, to allow uniform reporting within and outside clinical trials. In this Review, we clarify several aspects of disease response assessment, along with endpoints for clinical trials, and highlight future directions for disease response assessments. {\textcopyright} 2016 Elsevier Ltd},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995917601\&doi=10.1016\%2fS1470-2045\%2816\%2930206-6\&partnerID=40\&md5=7391a1548755424ae9cdf646f73bc942},
	author = {Kumar, S. and Paiva, B. and Anderson, K.C. and Durie, B. and Landgren, O. and Moreau, P. and Munshi, N. and Lonial, S. and Blad{\'e}, J. and Mateos, M.-V. and Dimopoulos, M. and Kastritis, E. and Boccadoro, M. and Orlowski, R. and Goldschmidt, H. and Spencer, A. and Hou, J. and Chng, W.J. and Usmani, S.Z. and Zamagni, E. and Shimizu, K. and Jagannath, S. and Johnsen, H.E. and Terpos, E. and Reiman, A. and Kyle, R.A. and Sonneveld, P. and Richardson, P.G. and McCarthy, P. and Ludwig, H. and Chen, W. and Cavo, M. and Harousseau, J.-L. and Lentzsch, S. and Hillengass, J. and Palumbo, A. and Orfao, A. and Rajkumar, S.V. and Miguel, J.S. and Avet-Loiseau, H.}
}
